KDR and breast carcinoma: These compounds are predicted to stably interact with the MMP12, CDK4, JAK3, VEGFR2, MMP13, VEGFR1, and KCNA3 proteins, which have a role in inhibiting the growth and inducing apoptosis in breast cancer cells.